On amendments to the general characteristics (SMPC) and instructions for medical use (leaflet, PIL) of medicinal products containing Perindopril as an active ingredient

2021-10-29T17:03:56+03:00

The instruction should include information about the Syndrome of inadequate secretion of ADH, depression, hot flashes, anuria/oliguria, acute liver failure data source and details